These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 3008993)
1. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993 [TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS. Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047 [TBL] [Abstract][Full Text] [Related]
3. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters. Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786 [TBL] [Abstract][Full Text] [Related]
4. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Biberfeld P; Porwit-Ksiazek A; Böttiger B; Morfeldt-Månsson L; Biberfeld G Cancer Res; 1985 Sep; 45(9 Suppl):4665s-4670s. PubMed ID: 2410110 [TBL] [Abstract][Full Text] [Related]
6. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953 [TBL] [Abstract][Full Text] [Related]
7. Relation of HTLV-III seropositivity and lymphadenopathy. Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732 [TBL] [Abstract][Full Text] [Related]
8. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Murray HW; Scavuzzo DA; Kelly CD; Rubin BY; Roberts RB Arch Intern Med; 1988 Jul; 148(7):1613-6. PubMed ID: 3132901 [TBL] [Abstract][Full Text] [Related]
16. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. Klein RS; Harris CA; Small CB; Moll B; Lesser M; Friedland GH N Engl J Med; 1984 Aug; 311(6):354-8. PubMed ID: 6738653 [TBL] [Abstract][Full Text] [Related]
17. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593 [TBL] [Abstract][Full Text] [Related]
18. Acquired immunodeficiency syndrome (AIDS) in homosexual men--a new public health concern. Strand OA NIPH Ann; 1982 Dec; 5(2):41-9. PubMed ID: 6302568 [TBL] [Abstract][Full Text] [Related]
19. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico]. Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666 [No Abstract] [Full Text] [Related]
20. [Gastrointestinal manifestations of acquired immunodeficiency syndrome; case studies of 14 patients]. Bengoa JM; Widgren S Schweiz Med Wochenschr; 1986 Oct; 116(40):1358-66. PubMed ID: 3775342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]